A New Immune Clock That Separates Cell Aging from Body Aging

Most biological aging clocks work by averaging signals across millions of cells at once. They measure bulk populations - a mix of immune cell types - and return a single number representing approximate biological age. That approach has proven useful in research, but it has a fundamental blind spot: it cannot tell whether the aging signal is coming from changes inside individual cells or from shifts in which types of cells are present in the first place.

A team led by Eric Verdin at the Buck Institute for Research on Aging has built a tool designed to solve that problem. Their single-cell transcriptomic clock, called Tictock - for T immune cell transcriptomic clock - measures aging within six specific T-cell subtypes individually, then separates two distinct processes: systemic aging, which shows up as changes in cell-type proportions, and intrinsic aging, which occurs within defined cells at the molecular level. The work was published in Aging-US.

How Tictock was built

The team trained the clock on single-cell RNA sequencing data from nearly two million immune cells drawn from the blood of healthy adults. Single-cell RNA sequencing measures which genes are active in each individual cell, rather than averaging gene expression across a tissue sample. That cellular resolution is what allows Tictock to assign an age estimate to specific cell types rather than to a composite mixture.

Tictock automates the classification of cells into six canonical T-cell subtypes and applies separate age prediction models to each. The architecture is deliberate: by assigning age estimates at the subtype level, the tool can distinguish between a sample that looks "old" because its population has shifted toward aging cell types (systemic aging) and one that looks "old" because individual cells within a specific type are showing molecular aging signs (intrinsic aging).

COVID-19 and HIV produce different patterns

When the researchers applied Tictock to patients with acute COVID-19, they found two overlapping effects. The infection altered the composition of T cells - the proportions of different subtypes shifted, with significant reductions in naive CD8 and naive CD4 T cells. Separately, the biological age of naive CD8 T cells increased. Both systemic and intrinsic aging were occurring simultaneously.

HIV presented a different picture. In people living with HIV who were on long-term antiretroviral therapy, T-cell proportions remained largely stable - the systemic aging component was modest. But naive CD8 T cells still showed signs of accelerated intrinsic aging, even with viral replication suppressed by treatment. The two infections leave distinct immunological fingerprints, and Tictock was able to characterize them separately.

A molecular signature pointing to ribosomes

Across all six T-cell subtypes and both conditions, the researchers found shared molecular pathways associated with age prediction. Many of the genes driving the age signal were involved in ribosome function - the cellular machinery responsible for producing proteins. Genes associated with the cytosolic small ribosomal subunit, TNF receptor binding, and cytosolic ribosome components appeared consistently across the clock models.

The researchers also observed that older immune cells tended to have shorter average transcript lengths - a pattern previously linked to aging in other contexts. These findings suggest that changes in protein production and gene regulation are central to immune cell aging, rather than being incidental features of it.

What Tictock is and is not designed to measure

The clock is specifically designed to measure relative aging within defined T-cell populations, not to estimate overall biological age as a general number. That is a more limited but more precise objective. By focusing on a specific cell type, it can detect subtle changes that would be averaged away in a bulk measurement.

Several important limitations apply. The training data came from healthy adults, and it is not yet established how well the model generalizes to people with chronic disease, very different ages, or populations not represented in the training set. The study was also observational - Tictock identified associations between viral infection and accelerated T-cell aging but cannot establish causality or rule out confounding from medications, comorbidities, or other factors. The tool measures transcriptomic age, which reflects gene activity patterns rather than structural cellular damage, and the relationship between transcriptomic age and clinical outcomes remains to be established.

Potential applications in immune risk assessment

If Tictock's performance holds up in further validation studies, it could serve as a more sensitive tool for assessing immune aging in clinical and research settings. Identifying which component of aging - systemic or intrinsic - is dominant in a given patient or condition might inform targeted interventions. Therapies aimed at restoring T-cell populations would address systemic aging; those aimed at reversing molecular changes within cells would address intrinsic aging. Distinguishing between the two is a prerequisite for choosing correctly.

The Buck Institute team plans further validation across additional disease contexts and population groups. For now, Tictock represents a methodological step forward in immune aging research - a way of asking more specific questions about why the immune system declines and where that decline begins.